Form 4: Janux Therapeutics Director Receives Shares via In-Kind Distribution
SEC Form 4 Filing
Director Vickie L Capps receives 2,305 shares of Janux Therapeutics common stock through an in-kind distribution from ABV SPV I GP LLC.
Summary
- On November 5, 2024, Vickie L Capps, a director of Janux Therapeutics, Inc., acquired 2,305 shares of common stock.
- The acquisition was part of a pro rata, in-kind distribution of securities by ABV SPV I GP LLC, of which Ms. Capps is a member.
- The price per share was $0.
- Following the transaction, Ms. Capps beneficially owns 70,348 shares of Janux Therapeutics common stock.
Sentiment
Score: 5
Explanation: This is a neutral regulatory filing, reflecting a standard transaction. It doesn't inherently indicate positive or negative sentiment.
Industry Context
Form 4 filings are standard disclosures required by the SEC to provide transparency into the transactions of company insiders, such as directors and officers, ensuring fair market practices.
Key Dates
| Date | Description |
|---|---|
| 11/05/2024 | Date of transaction: Vickie L Capps acquired 2,305 shares of Janux Therapeutics common stock. |
| 11/07/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.